Plasmin/alpha2-antiplasmin Complexes (PAP) in Lung Cancer Patients: Effects of Radiotherapy

Thromb Haemost 2002; 88(01): 169-170
DOI: 10.1055/s-0037-1613178

Letters to the Editor

Schattauer GmbH

Mieczyslaw Uszyński

¹Departments of Propedeutics of Medicine, Poland

,

Ewa Ziólkowska

²Departments of Regional Centre of Oncology in Bydgoszcz, Poland

,

Ewa Żekanowska

³Pathophysiology, The Ludwik Rydygier Medical University in Bydgoszcz

,

Waldemar Uszyńki

¹Departments of Propedeutics of Medicine, Poland

References
1 Taguchi O, Gabbazza EC, Yoshida M, Yamakami T, Kobayashi H, Shima T. High plasma level of plasmin-alpha 2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer. Clin Chim Acta 1996; 244: 69-81.
2 Seitz R, Rappe N, Kraus M, Immel A, Wolf M, Maasberg M, Egbring R. Pfab R, Havemann K. Activation of coagulation and fibrinolysis in patients with lung cancer; relation to tumour stage and prognosis. Blood Coagul Fibrinolysis 1993; 04: 249-54.